drugset / Trial / NCT02840617
ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes
NaSingle-groupOpen-labelDiagnostic
Summary
This study aims to evaluate the feasibility of indocyanine green (ICG)-based fluorescence imaging in the detection of prostate tumors and metastatic lymph nodes. By correlating the ICG fluorescence patterns with pathologically confirmed tumor and nodal status, it would be possible to use fluorescence navigation system in helping prostate biopsy and lymph node dissection in the future.
Timeline
- Start
- 2016-03
- Primary completion
- 2018-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.4 mg/kg | Intravenous |